Skip to content

R&D at other companies

Belden logo
BeldenBDC
$30.09M+5.9%
Cabot Corporation logo
Cabot CorporationCBT
$14M-6.7%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$30M+18.6%
Vontier logo
VontierVNT
$41.4M+3.0%
Archer Aviation logo
Archer AviationACHR
$171.7M+65.6%
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$27.48M+42.2%

Other financials

Income statement

See full
Revenue$27.0M+11.5%
Gross profit$23.3M+12.2%
Operating income-$5.1M-16.0%
Net income-$4.5M-34.0%
EPS (diluted)-$0.21-200%

Balance sheet

See full
Cash & equivalents$21.4M+13.6%
Total debt$16.9M+249%
Total equity$338.2M+25.7%
Total assets$388.2M+25.2%

Cash flow

See full
Operating cash flow-$4.9M+34.0%
CapEx$2.3M+644%
Free cash flow-$7.2M+6.7%

Valuation

See full
Market cap$1.25B+154%
Enterprise value$1.25B+161%
P/S11.2×+6.6×

Profitability

See full
Gross margin89.9%
Operating margin-0.3%
Net margin-10.5%+26.2pp
FCF margin1%

Returns & leverage

See full
Return on equity-3.9%+4.7pp
Debt / equity0.0×
Current ratio10.3×+2.8×

Where this comes from

Reported directly by Ceva in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Ceva’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ceva's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ceva's R&D?
Ceva (CEVA) reported R&D of $19.84M in Q1 2026.
How has Ceva's R&D changed year-over-year?
Ceva's R&D increased by 12.7% year-over-year, from $17.61M to $19.84M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.